SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-21-252773
Filing Date
2021-08-20
Accepted
2021-08-20 16:21:00
Documents
2
Group Members
JONATHAN FLINTPOLARIS HEALTHCARE TECHNOLOGY OPPORTUNITIES FUND GP, L.L.C.POLARIS HEALTHCARE TECHNOLOGY OPPORTUNITIES FUND, L.P.POLARIS PARTNERS GP IX, L.L.C.POLARIS PARTNERS IX, L.P.POLARIS VENTURE MANAGEMENT CO. V, L.L.C.POLARIS VENTURE PARTNERS ENTREPRE

Document Format Files

Seq Description Document Type Size
1 SC 13D d196418dsc13d.htm SC 13D 231859
2 EX-99.1 d196418dex991.htm EX-99.1 12059
  Complete submission text file 0001193125-21-252773.txt   246019
Mailing Address ONE MARINA PARK DRIVE 10TH FLOOR BOSTON MA 02210
Business Address ONE MARINA PARK DRIVE 10TH FLOOR BOSTON MA 02210 781-290-0770
Polaris Venture Partners V, L.P. (Filed by) CIK: 0001439590 (see all company filings)

IRS No.: 204234825 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 303 WYMAN STREET SUITE 300 WALTHAM MA 02451
Business Address 303 WYMAN STREET SUITE 300 WALTHAM MA 02451 (781) 530-3600
Adagio Therapeutics, Inc. (Subject) CIK: 0001832038 (see all company filings)

IRS No.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92804 | Film No.: 211194086
SIC: 2836 Biological Products, (No Diagnostic Substances)